Search Results - "Backert L"

Author Correction: Autologous T cell therapy for PRAME⁺ advanced solid tumors in HLA-A*02⁺ patients: a phase 1 trial.

Authors: Wermke M Araujo DM Chatterjee M et al.

Source: Nature medicine [Nat Med] 2025 Jul; Vol. 31 (7), pp. 2453.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE

Establishment of an I-ELISA method based on multi-epitope fusion protein for diagnosis of human brucellosis.

Authors: Xie, Yujia Guo, Liping Qi, Xinru et al.

Source: PLoS Neglected Tropical Diseases. 4/7/2025, Vol. 19 Issue 4, p1-12. 12p.

High-Temperature Corrosion of Fe-Cr Alloys in Water and HCl Vapor Environments at 500–600 °C.

Authors: Alcántara-Cárdenas, Juan Alberto Ramírez-López, Adán Chávez-Alcalá, José Federico et al.

Source: Solids (2673-6497). Feb2026, Vol. 7 Issue 1, p3. 23p.

Pancreatic cancer–restricted cryptic antigens are targets for T cell recognition.

Authors: Ely, Zackery A. Kulstad, Zachary J. Gunaydin, Gurcan et al.

Source: Science. 5/8/2025, Vol. 388 Issue 6747, p1-20. 20p.

This result is not displayed to guests.
Login for full access.

A promising endeavor against human cytomegalovirus: Predominant epitopes-based recombinant subunit vaccine RHEc^{IE1/pp65/pp150}.

Authors: Li, Zonghui Jiang, Shasha Liu, Wenxuan et al.

Source: Virulence. Dec2025, Vol. 16 Issue 1, p1-19. 19p.

HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry.

Authors: Bichmann L Marcu A Kowalewski DJ et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Aug 31; Vol. 13 (8). Date of Electronic Publication: 2025 Aug 31.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Autologous T cell therapy for PRAME⁺ advanced solid tumors in HLA-A*02⁺ patients: a phase 1 trial.

Authors: Wermke M Araujo DM Chatterjee M et al.

Source: Nature medicine [Nat Med] 2025 Jul; Vol. 31 (7), pp. 2365-2374. Date of Electronic Publication: 2025 Apr 09.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Proteomic Profiling of Pre- and Post-Surgery Saliva of Glioblastoma Patients II: A Preliminary Investigation of the Complementary Low Molecular Mass Fraction.

Authors: Muntiu, Alexandra Vincenzoni, Federica Rossetti, Diana Valeria et al.

Source: International Journal of Molecular Sciences. Oct2025, Vol. 26 Issue 20, p9995. 22p.

TRIP13-induced NUSAP1 upregulation promotes CcRCC progression through EMT and PI3K/AKT/mTOR pathway.

Authors: Chen, Xiaolong Wang, Qing Zhu, Zhiqiang et al.

Source: Journal of Translational Medicine. 8/11/2025, Vol. 23 Issue 1, p1-20. 20p.

Al- and Ta-Modified Alloy 740 Superalloy Castings Produced in Non-vacuum Conditions—Microstructure and Selected Properties.

Authors: Grudzień-Rakoczy, Małgorzata Rakoczy, Łukasz Lech, Sebastian et al.

Source: Metallurgical & Materials Transactions. Part A; Oct2024, Vol. 55 Issue 10, p3839-3858, 20p

mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules.

Authors: Hosseini Kakroudi M Rezvanimehr A Zolfaghari K et al.

Source: Discover oncology [Discov Oncol] 2026 Apr 04; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 04.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

LINE-1 Deregulation in Ovarian Cancer: Implications for Diagnosis, Prognosis, and Therapeutic Targeting.

Authors: Bonci N Schiavoni V Rexha J et al.

Source: Molecular diagnosis & therapy [Mol Diagn Ther] 2026 Jun 11. Date of Electronic Publication: 2026 Jun 11.

Publication Type: Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE

First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors.

Authors: Wermke M Holderried TAW Luke JJ et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jul 22; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 22.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Drug Discovery Strategies for Kallikrein-Related Peptidases.

Authors: Dreyer, Tobias Schuster, Daniela Magdolen, Viktor et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 1, p225. 45p.

B Cells Can Trigger the T-Cell-Mediated Autoimmune Response Against Melanocytes in Psoriasis.

Authors: He, Mengwen Bernhardt, Melissa Arakawa, Akiko et al.

Source: Cells (2073-4409). Dec2025, Vol. 14 Issue 24, p2002. 27p.

HCMV as an Oncomodulatory Virus in Ovarian Cancer: Implications of Viral Strain Heterogeneity, Immunomodulation, and Inflammation on the Tumour Microenvironment and Ovarian Cancer Progression.

Authors: Giatrakis, Chrissie Kartikasari, Apriliana E. R. Angelovich, Thomas A. et al.

Source: Biomolecules (2218-273X). Dec2025, Vol. 15 Issue 12, p1685. 31p.

Natural Killer (NK) Cell-Based Therapies Have the Potential to Treat Ovarian Cancer Effectively by Targeting Diverse Tumor Populations and Reducing the Risk of Recurrence.

Authors: Kaur, Kawaljit¹ (AUTHOR)

Source: Cancers. Dec2025, Vol. 17 Issue 23, p3862. 31p.

Mimicry in the Bite: Shared Sequences Between Aedes aegypti Salivary Proteins and Human Proteins.

Authors: Arévalo-Cortés, Andrea Rodriguez-Pinto, Daniel

Source: Proteomes. Dec2025, Vol. 13 Issue 4, p56. 26p.

Role of T cell metabolism in brain tumor development: a genetic and metabolic approach.

Authors: Yang, Bo Li, Zhenyu Li, Peiliang et al.

Source: BMC Neurology. 1/8/2025, Vol. 25 Issue 1, p1-8. 8p.